SYNLOGIC, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
SYNLOGIC, INC. (SYBX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$71.87 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-15
- SYNLOGIC, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$71.87M.
- SYNLOGIC, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$125.00K.
- SYNLOGIC, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $41.70M.
- SYNLOGIC, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was $1.29M.
- SYNLOGIC, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $9.28M.
- SYNLOGIC, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$1.83M.
- SYNLOGIC, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$251.00K.
- SYNLOGIC, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$102.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2018-03-31 | -$71.87M 10-Q · filed 2018-05-15 | ||||
| 2017-12-31 | $9.28M 10-K · filed 2018-03-20 | ||||
| 2017-03-31 | -$125.00K 10-Q · filed 2018-05-15 | $41.57M derived: sum of 2 quarters · filed 2018-05-15 | $42.87M derived: sum of 3 quarters · filed 2018-05-15 | $25.91M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $41.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $42.99M derived: sum of 2 quarters · filed 2018-03-20 | $26.03M derived: sum of 3 quarters · filed 2018-03-20 | -$1.83M 10-K · filed 2018-03-20 | -$48.49M 10-K · filed 2017-03-15 |
| 2016-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$15.67M derived: sum of 2 quarters · filed 2016-11-10 | -$43.53M 10-Q · filed 2016-11-10 | -$43.60M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2016-06-30 | -$16.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$44.83M 10-Q · filed 2016-08-15 | -$44.89M derived: sum of 3 quarters · filed 2017-03-15 | -$45.02M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2016-03-31 | -$27.86M 10-Q · filed 2016-05-12 | -$27.93M derived: sum of 2 quarters · filed 2017-03-15 | -$28.06M derived: sum of 3 quarters · filed 2017-03-15 | -$28.11M derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$193.00K derived: sum of 2 quarters · filed 2017-03-15 | -$246.00K derived: sum of 3 quarters · filed 2017-03-15 | -$251.00K 10-K · filed 2017-03-15 | |
| 2015-09-30 | -$129.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$182.00K derived: sum of 2 quarters · filed 2016-11-10 | -$187.00K 10-Q · filed 2016-11-10 | -$259.00K derived: sum of 4 quarters · filed 2017-03-15 | |
| 2015-06-30 | -$53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$58.00K 10-Q · filed 2016-08-15 | -$130.00K derived: sum of 3 quarters · filed 2017-03-15 | ||
| 2015-03-31 | -$5.00K 10-Q · filed 2016-05-12 | -$77.00K derived: sum of 2 quarters · filed 2017-03-15 | |||
| 2014-12-31 | -$72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$102.00K 10-K · filed 2017-03-15 | |||
| 2014-09-30 | -$30.00K 10-Q · filed 2015-11-13 | ||||
| 2013-12-31 | -$7.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |